FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166896195> ?p ?o ?g. }

• W2166896195 endingPage "416" @default.
• W2166896195 startingPage "411" @default.
• W2166896195 abstract "In children with mild-to-moderate persistent asthma, identification of phenotypic predictors to guide selection of a controller regimen is essential.We sought to identify phenotypic characteristics having predictive value for the difference in treatment responses between twice-daily fluticasone and once-daily montelukast.Data from the Pediatric Asthma Controller Trial were assessed with multivariate analysis. Outcomes included the change in asthma control days (ACDs), FEV(1), peak expiratory flow, and time to first asthma exacerbation measured over a 1-year treatment period.The mean age was 9.6 +/- 2.1 years, 60% were male, 50% had a parental history of asthma, and 78% had positive aeroallergen skin prick test responses. The mean percent predicted prebronchodilator FEV(1) was 97.8% +/- 12.9%, the median PC(20) value was 0.93 mg/mL, and the median exhaled nitric oxide (eNO) level was 25.2 ppb. A history of parental asthma best predicted the expected treatment benefit with fluticasone compared with montelukast in terms of gain in ACDs (adjusted P = .02) and time to first exacerbation (adjusted P = .05). Increased baseline eNO levels predicted the differential treatment response for fluticasone regarding the gain in ACDs (adjusted P = .01). Prior inhaled corticosteroid (ICS) use (adjusted P = .01) and low PC(20) values (adjusted P = .03) each predicted the expected treatment benefit with fluticasone over montelukast regarding time to first exacerbation. No phenotypic characteristics predicted treatment benefits for montelukast over fluticasone for either outcome.Physicians treating children with a parental history of asthma, increased eNO levels, low PC(20) values, or a history of ICS use can expect the best long-term outcomes with ICS therapy compared with treatment with leukotriene receptor antagonists." @default.
• W2166896195 created "2016-06-24" @default.
• W2166896195 creator A5012934813 @default.
• W2166896195 creator A5031055479 @default.
• W2166896195 creator A5033765434 @default.
• W2166896195 creator A5056700648 @default.
• W2166896195 creator A5057890262 @default.
• W2166896195 creator A5067390645 @default.
• W2166896195 creator A5069917433 @default.
• W2166896195 creator A5073820234 @default.
• W2166896195 creator A5080168791 @default.
• W2166896195 creator A5086533674 @default.
• W2166896195 creator A5087955329 @default.
• W2166896195 date "2009-02-01" @default.
• W2166896195 modified "2023-10-01" @default.
• W2166896195 title "Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma" @default.
• W2166896195 cites W1947556504 @default.
• W2166896195 cites W1968660451 @default.
• W2166896195 cites W1975176727 @default.
• W2166896195 cites W2001762327 @default.
• W2166896195 cites W2008384463 @default.
• W2166896195 cites W2014473048 @default.
• W2166896195 cites W2019767368 @default.
• W2166896195 cites W2036868974 @default.
• W2166896195 cites W2045868513 @default.
• W2166896195 cites W2049006289 @default.
• W2166896195 cites W2050021817 @default.
• W2166896195 cites W2052053086 @default.
• W2166896195 cites W2075172386 @default.
• W2166896195 cites W2082695270 @default.
• W2166896195 cites W2087822066 @default.
• W2166896195 cites W2093840838 @default.
• W2166896195 cites W2100578775 @default.
• W2166896195 cites W2112468123 @default.
• W2166896195 cites W2117087882 @default.
• W2166896195 cites W2134902690 @default.
• W2166896195 cites W2151251006 @default.
• W2166896195 cites W2151589341 @default.
• W2166896195 cites W2166142092 @default.
• W2166896195 cites W2594805288 @default.
• W2166896195 cites W53646502 @default.
• W2166896195 doi "https://doi.org/10.1016/j.jaci.2008.11.016" @default.
• W2166896195 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2662352" @default.
• W2166896195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19121860" @default.
• W2166896195 hasPublicationYear "2009" @default.
• W2166896195 type Work @default.
• W2166896195 sameAs 2166896195 @default.
• W2166896195 citedByCount "101" @default.
• W2166896195 countsByYear W21668961952012 @default.
• W2166896195 countsByYear W21668961952013 @default.
• W2166896195 countsByYear W21668961952014 @default.
• W2166896195 countsByYear W21668961952015 @default.
• W2166896195 countsByYear W21668961952016 @default.
• W2166896195 countsByYear W21668961952017 @default.
• W2166896195 countsByYear W21668961952018 @default.
• W2166896195 countsByYear W21668961952019 @default.
• W2166896195 countsByYear W21668961952020 @default.
• W2166896195 countsByYear W21668961952021 @default.
• W2166896195 countsByYear W21668961952022 @default.
• W2166896195 countsByYear W21668961952023 @default.
• W2166896195 crossrefType "journal-article" @default.
• W2166896195 hasAuthorship W2166896195A5012934813 @default.
• W2166896195 hasAuthorship W2166896195A5031055479 @default.
• W2166896195 hasAuthorship W2166896195A5033765434 @default.
• W2166896195 hasAuthorship W2166896195A5056700648 @default.
• W2166896195 hasAuthorship W2166896195A5057890262 @default.
• W2166896195 hasAuthorship W2166896195A5067390645 @default.
• W2166896195 hasAuthorship W2166896195A5069917433 @default.
• W2166896195 hasAuthorship W2166896195A5073820234 @default.
• W2166896195 hasAuthorship W2166896195A5080168791 @default.
• W2166896195 hasAuthorship W2166896195A5086533674 @default.
• W2166896195 hasAuthorship W2166896195A5087955329 @default.
• W2166896195 hasBestOaLocation W21668961952 @default.
• W2166896195 hasConcept C126322002 @default.
• W2166896195 hasConcept C187212893 @default.
• W2166896195 hasConcept C2776042228 @default.
• W2166896195 hasConcept C2776322731 @default.
• W2166896195 hasConcept C2776804153 @default.
• W2166896195 hasConcept C2777014857 @default.
• W2166896195 hasConcept C2779028295 @default.
• W2166896195 hasConcept C2780333948 @default.
• W2166896195 hasConcept C2781142857 @default.
• W2166896195 hasConcept C2781212218 @default.
• W2166896195 hasConcept C71924100 @default.
• W2166896195 hasConceptScore W2166896195C126322002 @default.
• W2166896195 hasConceptScore W2166896195C187212893 @default.
• W2166896195 hasConceptScore W2166896195C2776042228 @default.
• W2166896195 hasConceptScore W2166896195C2776322731 @default.
• W2166896195 hasConceptScore W2166896195C2776804153 @default.
• W2166896195 hasConceptScore W2166896195C2777014857 @default.
• W2166896195 hasConceptScore W2166896195C2779028295 @default.
• W2166896195 hasConceptScore W2166896195C2780333948 @default.
• W2166896195 hasConceptScore W2166896195C2781142857 @default.
• W2166896195 hasConceptScore W2166896195C2781212218 @default.
• W2166896195 hasConceptScore W2166896195C71924100 @default.
• W2166896195 hasFunder F4320337338 @default.
• W2166896195 hasIssue "2" @default.
• W2166896195 hasLocation W21668961951 @default.

• next